Pharma Consultant

Global atrial fibrillation market is expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%

Posted on

Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which are indicated for the treatment of AF such as Xarelto, Eliquis, Pradaxa and Savaysa.

DelveInsight Atrial Fibrillation-Market Insights & Drugs Sales Forecast (AF) -2020 provides an overview of Atrial Fibrillation indication. The Report majorly emphasize on the global Anticoagulants market size and market size of the Anticoagulants by 7Major Markets (United States, EU5 (France, Germany, Italy, Spain, UK) and Japan). The Report also covers the market size of Atrial Fibrillation along with the market sales of the Key drugs by AF.  The Report provides comprehensive review of Market Drivers, Market barriers, Anticoagulants with coverage of detailed profile, Cost of therapy, Safety and Efficacy profiles and SWOT analysis.

With the new guideline by regulatory agencies has promoted the use of NOACs over warfarin. Atrial Fibrillation guidelines has also encouraged to use CHA2DS2-VASc score instead of the CHADS2 score for assessing stroke risk, which will cause a larger proportion of lower risk patients to receive anticoagulant treatment.

For more information email us @ info@delveinsight.com.

Advertisements

Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020

Posted on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.

Pancreatic Cancer -Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

Pancreatic Cancer-Market Insights, Epidemiology and Market Forecast-2020, provides clients with the detailed insights into epidemiology and market forecast of the indication in these countries. This report majorly includes:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2010-2020.
  • It also provides Market size of Pancreatic Cancer for United States, EU5 and Japan from 2010 and forecasted Market size to 2020. This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market. Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

DelveInsight is offering the Report at a price of USD 4,950 as a single user license, USD 9,900 as a site license and USD 14,850 as a Global/Enterprise License.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

Note: These types of reports require 7-10 working days.

About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Non-Hodgkin’s Lymphoma (NHL) – Market Insights, Epidemiology and Market Forecast-2020

Posted on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.

Non-Hodgkin’s Lymphoma (NHL) -Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

Non-Hodgkin’s Lymphoma (NHL)-Market Insights, Epidemiology and Market Forecast-2020, provides clients with the detailed insights into epidemiology and market forecast of the indication in these countries. This report majorly includes:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2010-2020.
  • It also provides Market size of Non-Hodgkin’s Lymphoma (NHL) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020. This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market. Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

DelveInsight is offering the Report at a price of USD 4,950 as a single user license, USD 9,900 as a site license and USD 14,850 as a Global/Enterprise License.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

Note: These types of reports require 7-10 working days.

About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Nonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology and Market Forecast-2020

Posted on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.

Nonalcoholic Steatohepatitis (NASH) -Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

Nonalcoholic Steatohepatitis (NASH)-Market Insights, Epidemiology and Market Forecast-2020, provides clients with the detailed insights into epidemiology and market forecast of the indication in these countries. This report majorly includes:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2010-2020.
  • It also provides Market size of Nonalcoholic Steatohepatitis (NASH) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020. This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market. Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

DelveInsight is offering the Report at a price of USD 4,950 as a single user license, USD 9,900 as a site license and USD 14,850 as a Global/Enterprise License.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

Note: These types of reports require 7-10 working days.

About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Acute Myeloid Leukemia (AML) – Market Insights, Epidemiology and Market Forecast-2020

Posted on Updated on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategic and discover the target areas & potential customers for their products.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.

Acute Myeloid Leukemia (AML) -Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

Acute Myeloid Leukemia (AML) -Market Insights, Epidemiology and Market Forecast-2020, provides clients with the detailed insights into epidemiology and market forecast of the indication in these countries. This report majorly includes:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan countries from 2010-2020.
  • It also provides Market size of Acute Myeloid Leukemia (AML) for United States, EU5 and Japan countries from 2010 and forecasted Market size to 2020. This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market. Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

DelveInsight is offering the Report at a price of USD 4,950 as a single user license, USD 9,900 as a site license and USD 14,850 as a Global/Enterprise License.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

Note: These types of reports require 7-10 working days.

About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Rheumatoid Arthritis (RA) -Market Insights, Epidemiology and Market Forecast-2020

Posted on Updated on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategic and discover the target areas & potential customers for their products.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.

Rheumatoid Arthritis (RA) -Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

Rheumatoid Arthritis (RA) -Market Insights, Epidemiology and Market Forecast-2020, provides clients with the detailed insights into epidemiology and market forecast of the indication in these countries. This report majorly includes:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2010-2020.
  • It also provides Market size of Rheumatoid Arthritis (RA) for United States, EU5 and Japan countries from 2010 and forecasted Market size to 2020. This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market. Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

DelveInsight is offering the Report at a price of USD 4,950 as a single user license, USD 9,900 as a site license and USD 14,850 as a Global/Enterprise License.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

Note: These types of reports require 7-10 working days.

About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Indication-Market Insights, Epidemiology and Market Forecast,2010-2020:DelveInsight’s New Launch

Posted on Updated on

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products.

The database of DelveInsight currently has over 3000 reports which elaborate the domains of Indication Insight, Mechanism of Action, Drug Insights and API Insights. In addition to that, DelveInsight is providing Therapeutic intelligence to the companies with Strategic reports on Immuno-Oncology, Gene Therapy, Stem Cell Therapy, Antibody-Drug Conjugates and many more.

Market insights, epidemiology and market forecasting reports provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view.

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports.  With the dedicated analytical and forecasting team, DelveInsight has released 13 Reports on Market insights, epidemiology and market forecast Reports. These Reports will provide an insight on the forecast of the indication in seven major markets during 2010-2020. The epidemiological forecast for the diagnosed prevalence of the disease in 7MM is supported by the data which has been obtained from studies conducted in the respective countries.

Therapeutic Areas Focused

  • Acute Myeloid Leukemia (AML)
  • Duchenne Muscular Dystrophy
  • Hemophilia
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Multiple Myeloma
  • Nonalcoholic Steatohepatitis (NASH)
  • Non-Hodgkin’s Lymphoma (NHL)
  • Pancreatic Cancer
  • Pulmonary Arterial Hypertension (PAH)
  • Respiratory Syncytial virus (RSV)
  • Rheumatoid Arthritis (RA)
  • Short Bowel Syndrome
  • Ulcerative Colitis (UC)

Market Forecast

The Indication- market insights, epidemiology and market forecast 2010-2020, provides clients the detailed insights into epidemiology of the indication in these countries. This report majorly includes:

  • Country specific forecast for the indication during 2010-2020.
  • The risk factors, comorbidities and global trends for the disease in the 7MM.
  • High quality, elucidating, transparent and market-driven report, providing expert analysis of disease trends in the 7MM.

This epidemiological analysis report will aid in the development of business strategies by providing a deep understanding of the trend shaping and driving the global insight market.  Along with that, it quantifies the patient populations in the global indication market to improve product design, pricing, and launch plans.

For more information on Indication – Market insights, Epidemiology and Market Forecast 2010-2020, email at info@delveInsight.com

 About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.